Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
Emmanouil GlampedakisRomain RothStavroula Masouridi-LevratYves ChalandonAnne-Claire MamezFederica GiannottiChristian Van DeldenDionysios NeofytosPublished in: Journal of fungi (Basel, Switzerland) (2021)
Combination antifungal treatment is frequently administered in allogeneic HCT recipients with IMI to improve clinical efficacy, albeit in an inconsistent and variable manner, suggesting a lack of relevant data and guidance, and an urgent need for new studies to improve therapeutic options.